Functional characterization of HUVEC-CS: Ca2+ signaling, ERK 1/2 activation, mitogenesis and vasodilator production

Journal of Endocrinology

Volumn 182, Issue 3, 2004, Pages 485-499

  Gifford, S M ^a   Grummer, M A ^a   Pierre, S A ^a   Austin, J L ^a   Zheng, J ^a   Bird, I M ^a  

^a UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYL LOW DENSITY LIPOPROTEIN; ADENOSINE TRIPHOSPHATE; ANGIOTENSIN; ANGIOTENSIN RECEPTOR; ARGININE; BASIC FIBROBLAST GROWTH FACTOR; BRADYKININ; BRADYKININ RECEPTOR; CADHERIN; CALCIUM ION; CAVEOLIN 1; CAVEOLIN 2; CD31 ANTIGEN; CITRULLINE; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; ENDOTHELIAL NITRIC OXIDE SYNTHASE; EPIDERMAL GROWTH FACTOR; GROWTH FACTOR RECEPTOR; HEAT SHOCK PROTEIN 90; MATRIGEL; MITOGEN ACTIVATED PROTEIN KINASE 1; PHOSPHOLIPASE A2; PROSTACYCLIN; PROSTAGLANDIN DERIVATIVE; PROSTAGLANDIN SYNTHASE; PURINE P2X RECEPTOR; PURINE P2Y RECEPTOR; THAPSIGARGIN; VASCULOTROPIN; VASODILATOR AGENT;

ARTICLE; CALCIUM CELL LEVEL; CALCIUM SIGNALING; CAPILLARY; CELL FUNCTION; CELL GROWTH; CELL IMMORTALIZATION; CELL LINE; CELL PROLIFERATION; CONTROLLED STUDY; CULTURE MEDIUM; ENDOTHELIUM CELL; ENZYME ACTIVATION; ENZYME ACTIVITY; HUMAN; HUMAN CELL; MITOGENESIS; PRIORITY JOURNAL; PROSTAGLANDIN SYNTHESIS; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN TRANSPORT; UMBILICAL VEIN; WESTERN BLOTTING;

ADENOSINE TRIPHOSPHATE; CALCIUM SIGNALING; CELL CULTURE TECHNIQUES; CELL LINE; DOSE-RESPONSE RELATIONSHIP, DRUG; ENDOTHELIAL CELLS; ENZYME ACTIVATION; HUMANS; MITOGEN-ACTIVATED PROTEIN KINASES; MITOSIS; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE TYPE III; UMBILICAL VEINS; VASODILATOR AGENTS;

EID: 4644318740     PISSN: 00220795     EISSN: None     Source Type: Journal    
DOI: 10.1677/joe.0.1820485     Document Type: Article

References (61)

1. Andreozzi F, Laratta E, Sciacqua A, Perticone F & Sesti G 2004 Angiotensin II impairs the insulin signaling pathway promoting production of nitric oxide by inducing phosphorylation of insulin receptor substrate-1 on Ser312 and Ser616 in human umbilical vein endothelial cells. Circulation Research 94 1211-1218.
2. 2+ influx upon hypoxia. Journal of Cellular Biochemistry 78 458-464.
3. Bird IM, Sullivan JA, Di T, Cale JM, Zhang L, Zheng J & Magness RR 2000 Pregnancy-dependent changes in cell signaling underlie changes in differential control of vasodilator production in uterine artery endothelial cells. Endocrinology 141 1107-1117.
4. Boulanger CM & Vanhoutte PM 1997 G proteins and endothelium-dependent relaxations. Journal of Vascular Research 34 175-185.
5. Brown J, Reading SJ, Jones S, Fitchett CJ, Howl J, Martin A, Longland CL, Michelangeli F, Dubrova YE & Brown CA 2000 Critical evaluation of ECV304 as a human endothelial cell model defined by genetic analysis and functional responses: a comparison with the human bladder cancer derived epithelial cell line T24/83. Laboratory Investigation 80 37-45.
6. Bustos M, Coffman TM, Saadi S & Platt JL 1997 Modulation of eicosanoid metabolism in endothelial cells in a xenograft model: role of cyclooxygenase-2. Journal of Clinical Investigation 100 1150-1158.
7. Caughey GE, Cleland LG, Penglis PS, Gamble JR & James MJ 2001 Roles of cyclooxygenase (COX)-1 and COX-2 in prostanoid production in human endothelial cells: selective up-regulation of prostacyclin synthesis by COX-2. Journal of Immunology 167 2831-2838.
8. Chi J, Chang HY, Haraldsen G, Jahnsen FL, Troyanskaya OG, Chang DS, Wang Z, Rockson SG, van de Rijn M, Botstein D & Brown PO 2003 Endothelial cell diversity revealed by global expression profiling. PNAS 100 10623-10628.
9. 2+-dependent synthesis of prostacyclin in ATP-stimulated venous endothelial cells. Hypertension 39(2 Pt 2) 581-585.
10. Corson MA, James NL, Latta SE, Nerem RM, Berk BC & Harrison DG 1996 Phosphorylation of endothelial nitric oxide synthase in response to fluid shear stress. Circulation Research 79 984-991.
11. Couet J, Li S, Okamoto T, Ikezu T & Lisanti MP 1997 Identification of peptide and protein ligands for the caveolin-scaffolding domain. Implications for the interaction of caveolin with caveolae-associated proteins. Journal of Biological Chemistry 272 6525-6533.
12. Desideri G, Bravi MC, Tucci M, Croce G, Marincci MC, Santucci A, Alesse E & Ferri C 2003 Angiotensin II inhibits endothelial motility through an AT1-dependent oxidant-sensitive decrement of nitric oxide availability. Arteriosclerosis, Thrombosis, and Vascular Biology 23 1218-1223.
13. DeWeerd WF & Leeb-Lundberg LM 1997 Bradykinin sequesters B2 bradykinin receptors and the receptor-coupled Gαq and Gαi in caveolae in DDT1 MF-2 smooth muscle cells. Journal of Biological Chemistry 272 17858-17866.
14. 2. Endocrinology 142 1-13.
15. Dimmeler S, Fleming I, Fisslthaler B, Hermann C, Busse R & Zeiher AM 1999 Activation of nitric oxide synthase in endothelial cells by Akt-dependent phosphorylation. Nature 399 601-605.
16. Edgell CJ, McDonald CC & Graham JB 1983 Permanent cell line expressing human factor VIII-related antigen established by hybridization. PNAS 80 3734-3737.
17. Feron O, Belhassen L, Kobzik L, Smith TW, Kelly RA & Michel T 1996 Endothelial nitric oxide synthase targeting to caveolae. Specific interactions with caveolin isoforms in cardiac myocytes and endothelial cells. Journal of Biological Chemistry 271 22810-22814.
18. Fleming I & Busse R 2003 Molecular mechanisms involved in the regulation of the endothelial nitric oxide synthase. American Journal of Physiology - Regulatory Integrative and Comparative Physiology 284 R1-R12.
19. Fontana J, Fulton D, Chen Y, Fairchild TA, McCabe TJ, Fujita N, Tsuruo T & Sessa WC 2002 Domain mapping studies reveal that the M domain of hsp90 serves as a molecular scaffold to regulate Akt-dependent phosphorylation of endothelial nitric oxide synthase and NO release. Circulation Research 90 1-9.
20. Franklin SL, Ferry RJ & Cohen P 2003 Rapid insulin-like growth factor (IGF)-independent effects of IGF binding protein-3 on endothelial cell survival. Journal of Clinical Endocrinology and Metabolism 88 900-907.
21. García-Cardeña G, Fan R, Stern DF, Liu J & Sessa W 1996 Endothelial nitric oxide synthase is regulated by tyrosine phosphorylation and interacts with caveolin-1. Journal of Biological Chemistry 271 27237-27240.
22. García-Cardeña G, Fan R, Shah V, Sorrentino K, Cirino G, Papapetropoulos A & Sessa W 1998 Dynamic activation of endothelial nitric oxide synthase by HSP90. Nature 392 821-824.
23. Gifford SM, Cale JM, Tsoi S, Magness RR & Bird IM 2003 Pregnancy-specific changes in uterine artery endothelial cell signaling in vivo are both programmed and retained in primary culture. Endocrinology 144 3639-3650.
24. Hood JD, Frausto R, Kiosses WB, Schwartz MA & Cheresh DA 2003 Differential αv integrin-mediated Ras-ERK signaling during two pathways of angiogenesis. Journal of Cell Biology 162 933-943.
25. Houle F, Rousseau S, Morrice N, Luc M, Mongrain S, Turner CE, Tanaka S, Moreau P & Huot J 2003 Extracellular signal-regulated kinase mediates phosphorylation of tropomyosin-1 to promote cytoskeletal remodeling in response to oxidative stress: impact on membrane blebbing. Molecular Biology of the Cell 14 1418-1432.
26. Huang PL, Huang Z & Mashimo H 1995 Hypertension in mice lacking the gene for endothelial nitric oxide synthase. Nature 377 239-242.
27. Ido Y, Carling D & Ruderman N 2002 Hyperglycemia-induced apoptosis in human umbilical vein endothelial cells: inhibition by the AMP-activated protein kinase activation. Diabetes 51 159-167.
28. Jozkowicz A, Pankiewicz J, Dulak J, Partyka L, Wybranska I, Huk I & Dembinska-Kiec A 1999 Nitric oxide mediates the mitogenic effects of insulin and vascular endothelial growth factor but not of leptin in endothelial cells. Acta Biochimica Polonica 46 703-715.
29. Ju H, Zou R, Venema VJ & Venema RC 1997 Direct interaction of endothelial nitric-oxide synthase and caveolin-1 inhibits synthase activity. Journal of Biological Chemistry 272 18522-18525.
30. Kiessling F, Kartenbeck J & Haller C 1999 Cell-cell contacts in the human cell line ECV304 exhibit both endothelial and epithelial characteristics. Cell and Tissue Research 297 131-140.
31. Kimura C, Oike M, Koyama T & Ito Y 2001 Impairment of endothelial nitric oxide production by acute glucose overload. American Journal of Physiology - Endocrinology and Metabolism 280 E171-E178.
32. Kone BC 2000 Protein-protein interactions controlling nitric oxide synthase. Acta Physiologica Scandinavica 168 27-31.
33. Labrecque L, Royal I, Surprenant DS, Patterson C, Gingras D & Béliveau R 2003 Regulation of vascular endothelial growth factor receptor-2 activity by caveolin-1 and plasma membrane cholesterol. Molecular Biology of the Cell 14 334-337.
34. Lidington EA & Moyes DL 1999 A comparison of primary endothelial cells and endothelial cell lines for studies of immune interactions. Transplant Immunology 7 239.
35. MacLeod RAF, Dirks WG, Matsuo Y, Kaufmann M, Milch H & Drexler HG 1999 Widespread intraspecies cross-contamination of human tumor cell lines arising at source. International Journal of Cancer 83 555-563.
36. 2+-calmodulin and caveolin. Journal of Biological Chemistry 272 15583-15586.
37. Michel JB, Feron O, Sase K, Prabhakar P & Michel T 1997b Caveolin versus calmodulin. Counterbalancing allosteric modulators of endothelial nitric oxide synthase. Journal of Biological Chemistry 272 25907-25912.
38. Mineo C, James GL, Smart EJ & Anderson RG 1996 Localization of epidermal growth factor-stimulated Ras/Raf-1 interaction to caveolae membrane. Journal of Biological Chemistry 271 11930-11935.
39. Miralpeix M, Comacho M, López-Belmonte J, Canalías F, Beleta J, Palacios JM & Vila L 1997 Selective induction of cyclo-oxygenase-2 activity in the permanent human endothelial cell line HUV-EC-C: biochemical and pharmacological characterization. British Journal of Pharmacology 121 171-180.
40. Miura S, Tanigawa H, Matsuo Y, Fujino M, Kawamura A & Saku K 2003 Ras/Raf1-dependent signal in sphingosine-1-phosphate-induced tube formation in human coronary artery endothelial cells. Biochemical and Biophysical Research Communications 306 924-929.
41. 1179. Journal of Biological Chemistry 276 30392-30398.
42. Murthy KS & Makhlouf GM 1998 Coexpression of ligand-gated P2X and G protein-coupled P2Y receptors in smooth muscle. Journal of Biological Chemistry 273 4695-4704.
43. Parenti A, Morbidelli L, Cui X, Douglas JG, Hood JD, Granger HJ, Ledda F & Ziche M 1998 Nitric oxide is an upstream signal of vascular endothelial growth factor-induced extracellular signal-regulated kinase 1/2 activation in postcapillary endothelium. Journal of Biological Chemistry 273 4220-4226.
44. + current. Arteriosclerosis, Thrombosis, and Vascular Biology 24 1229-1233.
45. Schena M, Mulatero P, Schiavone D, Mengozzi G, Tesio L, Chiandussi L & Veglio F 1999 Vasoactive hormones induce nitric oxide synthase mRNA expression and nitric oxide production in human endothelial cells and monocytes. American Journal of Hypertension 12 388-397.
46. Schluter C, Duchrow M, Wohlenberg C, Becker MH, Key G, Flad HD & Gerdes J 1993 The cell proliferation-associated antigen of antibody Ki-67: a very large, ubiquitous nuclear protein with numerous repeated elements, representing a new kind of cell cycle-maintaining proteins. Journal of Cell Biology 123 513-522.
47. Schriffin EL 2001 A critical review of the role of endothelial factors in the pathogenesis of hypertension. Journal of Cardiovascular Pharmacology 38 (Suppl 2) S3-S6.
48. Smart EJ, Ying YS, Mineo C & Anderson RG 1995 A detergent-free method for purifying caveolae membrane from tissue culture cells. PNAS 92 10104-10108.
49. Strassheim D & Williams CL 2000 P2Y2 Purinergic and M3 muscarinic acetylcholine receptors activate different phospholipase C-β isoforms that are uniquely susceptible to protein kinase C-dependent phosphorylation and inactivation. Journal of Biological Chemistry 275 39767-39772.
50. Suda K, Rothen-Rutishauser B, Günthert M & Wunderli-Allenspach H 2001 Phenotypic characterization of human umbilical vein endothelial (ECV304) and urinary carcinoma (T24) cells: endothelial versus epithelial features. In Vitro Cellular and Developmental Biology-Animal 37 505-514.
51. Tachibana T, Endoh M, Kumakami R & Nawa T 2003 Immunohistochemical expression of mGluR5, P2Y2 receptor, PLC-beta1, and IP3R-I and -II in Merkel cells in rat sinus hair follicles. Histochemistry and Cell Biology 120 13-21.
52. Takahashi K, Sawasaki Y, Hata J, Mukai K & Goto T 1990 Spontaneous transformation and immortalization of human endothelial cells. In Vitro Cellular and Developmental Biology -Animal 25 265-274.
53. Takahashi S & Mendelsohn ME 2003 Synergistic activation of endothelial nitric-oxide synthase (eNOS) by HSP90 and Akt: calcium-independent eNOS activation involves formation of an HSP90-Akt-CaM-bound eNOS complex. Journal of Biological Chemistry 278 30821-30827.
54. Tanabe H, Takada Y, Minegishi D, Durematsu M, Mansui T & Mizusawa H 1999 Cell line individualization by STR multiplex system in the cell bank found cross-contamination between ECV304 and EJ-1/T24. Tissue Culture Research Communications 18 329-338.
55. 2+ signalling in endothelial cells. Cardiovascular Research 48 13-22.
56. Unger RE, Krump-Konvalinkova V, Peters K & Kirkpatrick CJ 2002 In vitro expression of the endothelial phenotype: comparative study of primary isolated cells and cell lines, including the novel cell line HPMEC-ST1.6R. Microvascular Research 64 384-397.
57. 2+ currents in adrenal medulla endothelial cells. American Journal of Physiology - Heart and Circulatory Physiology 45 H1313-H1322.
58. Wajih N & Sane DC 2003 Angiostatin selectively inhibits signaling by hepatocyte growth factor in endothelial and smooth muscle cells. Blood 101 1857-1863.
59. Waseem NH & Lane DP 1990 Monoclonal antibody analysis of the proliferating cell nuclear antigen (PCNA). Structural conservation and the detection of a nucleolar form. Journal of Cell Science 96 (Pt 1) 121-129.
60. 2+ channels in cerebral microvascular endothelial cells and ET-1 biosynthesis. American Journal of Physiology - Cell Physiology 283 C1687-C1695.
61. Zheng J 1998 Immunohistochemistry and immunocytochemistry. Methods in Molecular Biology 105 307-314.